| Literature DB >> 34312809 |
G Biganzoli1, D Dilillo2, E Biganzoli3, G Zuccotti2,4, V Calcaterra5,6, S Mannarino7, L Fiori2, G Pelizzo8, E Zoia9, V Fabiano2,4, P Carlucci2, A Camporesi9, C Corti7, G Mercurio2, F Izzo9.
Abstract
PURPOSE: COVID-19 disease may result in a severe multisystem inflammatory syndrome in children (MIS-C), which in turn may alter thyroid function (TF). We assessed TF in MIS-C, evaluating its impact on disease severity.Entities:
Keywords: Children; Multisystem inflammatory syndrome; Non-thyroidal illness syndrome; Overall Severity Score; SARS-CoV-2
Mesh:
Substances:
Year: 2021 PMID: 34312809 PMCID: PMC8312710 DOI: 10.1007/s40618-021-01647-9
Source DB: PubMed Journal: J Endocrinol Invest ISSN: 0391-4097 Impact factor: 4.256
Severity score according to system involvement
| Organ | Score | ||
|---|---|---|---|
| 0 | 1 | 2 | |
| Kidney | Normal creatinine | Increase in creatinine < 50% [ | Increase in creatinine > 50% [ |
| Heart | Ejection fraction > 45% [ | Ejection fraction 36–45% [ | Ejection fraction < 36% [ |
| Gastrointestinal system | None | Abdominal symptoms [ | Acute abdomen [ |
| Central nervous system | None | Neurological symptoms [ | Impaired consciousness [ |
| Lung | None | Non invasive respiratory support | Invasive ventilation |
| Immune (fever) | < 3 days | 3–7 days [ | > 7 days [ |
| Skin/mucosal involvement | None | Skin | Skin + mucosal |
Demographic and clinical characteristics of the enrolled patients
| Variable | Value |
|---|---|
| Age (years)* | 10.69 (5.78–13.28) |
| Sex (M/F) | 20/6 |
| Tanner stages (n. of patients) | |
| Tanner 1 | 13 |
| Tanner 2–3 | 7 |
| Tanner 3–4 | 6 |
| BMI * | 17.45 (16.24–20.43) |
| BMI | 0.26 (− 0.40–1.10) |
| Duration of hospitalization in pediatric intensive care unit | 3.0 (2.0–4.0) |
| Total duration of hospitalization | 12.00 (10.00–15.75) |
| Overall severity score* | 9.00 (8.00–10.00) |
| Severity Score 2 (n. of patients) | |
| Kidney | 2/26 |
| Heart | 5/26 |
| Gastrointestinal system | 0/26 |
| Central nervous system | 1/26 |
| Lung | 1/26 |
| Immune (fever) | 6/26 |
| Skin/mucosal involvement | 4/26 |
| Positive outcome | 26/26 |
*Data are expressed as the median and 25% and 75% quantiles
Biochemical characteristics of the enrolled patients
| Variable | Value | Normal value | Number of patients with pathological values |
|---|---|---|---|
| Fasting blood glucose levels (mg/dl)* | 111.0 (90.5–130.0) | < 100 | 18/26 |
| Fasting triglycerides (mg/dl)* | 195.0 (114.0–298.0) | < 150 | 14/25 |
| Trygliceride glucose index* | 9.221 (8.921–9.615) | < 7.88 | 25/25 |
| Total cholesterol (mg/dl)* | 120.0 (85.0–164.0) | < 190 | 4/23 |
| HDL cholesterol (mg/dl)* | 15.00 (4.00–24.00) | < 40 | 22/23 |
| Leucocytes (× 10^9/L)* | 9.64 (6.63–14.01) | < 2 years: 6–17; 2–8 years: 5.5–15.5; 8–16 years: 4.5–13.5; > 16 years: 4.5–13 | 11/26 |
| Platelets (× 10^9/L)* | 170.5 (121.5–230.0) | 150–500 | 9/26 |
| Hemoglobin (g/L)* | 107.50 (91.25–113.00) | < 2 years > 105; 2–12 years > 115; 12–18 years males > 130; 12–18 years females > 120 | 24/26 |
| Creatinine (mg/dl)* | 0.5250 (0.4225–0.5777) | 0.7–1.2 | 0/26 |
| Urea (mg/dl)* | 30.50 (19.75–45.00) | 19–50 | 6/26 |
| C-reactive protein (mg/dl)* | 259.6 (119.9–298.7) | < 10 | 26/26 |
| Procalcitonin (µg/L)* | 6.55 (2.15–18.45) | < 0.5 | 25/26 |
| NT-proBNP (ng/L)* | 9282 (4214–14,760) | < 125 | 26/26 |
| Troponin (ng/L) | 39.50 (16.75–112.00) | < 15 | 21/26 |
| Fibrinogen (g/L)* | 6.430 (6.430–6.780) | < 4 | 26/26 |
| INR* | 1.350 (1.240–1.427) | 0.84–1.16 | 23/26 |
| D-dimer (µg/L)* | 2734 (2003–4154) | < 200 | 26/26 |
| Creatine kinase (U/L)* | 63.50 (35.25–130.25) | Males: 47–322 Females: 29–201 | 3/26 |
| Na (mEq/L)* | 131.0 (128.0–134.0) | 135–145 | 19/26 |
| K (mEq/L)* | 3.500 (3.000–3.900) | 3.5–5 | 13/26 |
| Ferritin (µg/L)* | 675.5 (402.0–1491.8) | 7–140 | 26/26 |
| FT3 (pmol/L) | 2.45 (1.92–3.15) | 3.5–6.3 | 22/26 |
| FT4 (pmol/L) | 11.65 (10.32–13.73) | 9–19.3 | 7/26 |
| TSH (µIU/mL) | 2.16 (1.18–3.00) | 0.5–4.2 | 3/26 |
In particular, the parameters considered to define the MIS-C diagnosis are reported. Additionally, the triglyceride glucose (TyG) index is reported as a surrogate of insulin resistance
*Data are expressed as the median and 25% and 75% quantiles
Distribution and patterns of FT3, FT4 and TSH values
| Parameter | Number of patients (%) |
|---|---|
| Hormonal levels in all patients ( | |
| FT3 (nv 3.5–6.3 pmol/L) | |
| Normal | 4 (15.4) |
| Low | 22 (84.6) |
| FT4 (nv 9–19.3 pmol/L) | |
| Normal | 19 (73.1) |
| Low | 7 (26.9) |
| TSH (nv 0.5–4.2 µIU/mL) | |
| Normal | 23 (88.5) |
| Low | 2 (7.7) |
| High | 1 (3.8) |
| Hormonal pattern in patients with NTIS ( | |
| Low FT3 only, | 15 (65.3) |
| Low FT3, Low FT4, | 5 (21.7) |
| Low FT3, Low FT4, Low TSH | 2 (8.7) |
| High TSH, | 1 (4.3) |
nv normal values, NTIS non-thyroidal illness syndrome
Fig. 1The panel shows the four subspaces defined by the first four PCs (i.e., Dim1, Dim2, Dim3, Dim4). When the subspace defined by the two principal components describes the variables well, these are projected towards a circle unity radius, also known as the circle of correlation. The warmer the color of the vector, the better that variable is described by the plane defined by the PCs; the cooler the color of a variable vector, that variable is not as well described by the plane. As can be seen in (a, b), variables FT3, FT4 and the metabolic variable total cholesterol are well represented in the plane defined by Dim1 and Dim2 and in the plane defined by Dim2 and Dim3. Indeed, these are all positively correlated to each other and positively correlated to the second dimension. Moreover, in (a, c, d), the variables related to organ damage and inflammation are well represented in the planes and positively correlated to each other and to the first dimension (Dim1). Finally, in (b, c) where Dim3 participates in the definition of the plane, the variables TyG index and triglycerides are, as expected, strongly correlated to each other, and associated with the third dimension. In all of the planes (a, b, c, d) the variable Overall Severity Score is projected passively and, as expected, its vector points in the same direction as the variables related to organ damage and inflammation
Fig. 2The panel shows the four subspaces defined by the four PCs (i.e., Dim1, Dim2, Dim3 and Dim4). In this case, cut-off values were applied to show only the variables that were well represented by the planes defined by the PCs. As shown, the circles of correlation confirm the results displayed in Fig. 1, in which variables FT3, FT4 and total cholesterol are dependent on the presence of Dim2, those related to organ damage and inflammation are dependent on the presence Dim1 and the variables TyG index and triglycerides are dependent on the Dim3
Fig. 3The panel shows a correlogram in which the correlations observed between the variables and the dimensions in the PCA are displayed. Correlations are indicated with color and dimension-coded circles. The greater the intensity of the color and the larger dimension of the circle, the greater the correlation; and vice versa. The blue color spectrum is associated with a positive correlation, while the red color spectrum is associated with a negative correlation. The first dimension is strongly correlated with the variables related to organ damage and inflammation and also with the Overall Severity Score. Whereas, the second dimension is strongly correlated with variables FT3, FT4 and total cholesterol; positively correlated with the metabolic variables; and negatively correlated with the Overall Severity Score. It is notable that the third dimension—strongly and negatively associated with the variables TyG index and Triglycerides—is the most negatively associated with the Overall Severity Score